These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 38799423)

  • 1. Hypoxia-inducible factor in breast cancer: role and target for breast cancer treatment.
    Zhi S; Chen C; Huang H; Zhang Z; Zeng F; Zhang S
    Front Immunol; 2024; 15():1370800. PubMed ID: 38799423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs).
    De Francesco EM; Lappano R; Santolla MF; Marsico S; Caruso A; Maggiolini M
    Breast Cancer Res; 2013; 15(4):R64. PubMed ID: 23947803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melittin inhibits the expression of key genes involved in tumor microenvironment formation by suppressing HIF-1α signaling in breast cancer cells.
    Mir Hassani Z; Nabiuni M; Parivar K; Abdirad S; Karimzadeh L
    Med Oncol; 2021 Jun; 38(7):77. PubMed ID: 34076777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia inducible factor in hepatocellular carcinoma: A therapeutic target.
    Lin D; Wu J
    World J Gastroenterol; 2015 Nov; 21(42):12171-8. PubMed ID: 26576101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-mediated drug resistance in breast cancers.
    McAleese CE; Choudhury C; Butcher NJ; Minchin RF
    Cancer Lett; 2021 Apr; 502():189-199. PubMed ID: 33278499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Hypoxia-Inducible Factor-1-Mediated Metastasis for Cancer Therapy.
    Ma Z; Wang LZ; Cheng JT; Lam WST; Ma X; Xiang X; Wong AL; Goh BC; Gong Q; Sethi G; Wang L
    Antioxid Redox Signal; 2021 Jun; 34(18):1484-1497. PubMed ID: 33198508
    [No Abstract]   [Full Text] [Related]  

  • 7. Sanguinarine combats hypoxia-induced activation of EphB4 and HIF-1α pathways in breast cancer.
    Su Q; Wang J; Wu Q; Ullah A; Ghauri MA; Sarwar A; Chen L; Liu F; Zhang Y
    Phytomedicine; 2021 Apr; 84():153503. PubMed ID: 33636580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.
    Rohwer N; Cramer T
    Drug Resist Updat; 2011 Jun; 14(3):191-201. PubMed ID: 21466972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonhypoxic regulation and role of hypoxia-inducible factor 1 in aromatase inhibitor resistant breast cancer.
    Kazi AA; Gilani RA; Schech AJ; Chumsri S; Sabnis G; Shah P; Goloubeva O; Kronsberg S; Brodie AH
    Breast Cancer Res; 2014 Jan; 16(1):R15. PubMed ID: 24472707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
    Lappano R; Talia M; Cirillo F; Rigiracciolo DC; Scordamaglia D; Guzzi R; Miglietta AM; De Francesco EM; Belfiore A; Sims AH; Maggiolini M
    J Exp Clin Cancer Res; 2020 Aug; 39(1):153. PubMed ID: 32778144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The quinoxaline di-N-oxide DCQ blocks breast cancer metastasis in vitro and in vivo by targeting the hypoxia inducible factor-1 pathway.
    Ghattass K; El-Sitt S; Zibara K; Rayes S; Haddadin MJ; El-Sabban M; Gali-Muhtasib H
    Mol Cancer; 2014 Jan; 13():12. PubMed ID: 24461075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural products as potent inhibitors of hypoxia-inducible factor-1α in cancer therapy.
    Zhong JC; Li XB; Lyu WY; Ye WC; Zhang DM
    Chin J Nat Med; 2020 Sep; 18(9):696-703. PubMed ID: 32928513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anterior gradient 2 is a binding stabilizer of hypoxia inducible factor-1α that enhances CoCl2 -induced doxorubicin resistance in breast cancer cells.
    Li Z; Zhu Q; Hu L; Chen H; Wu Z; Li D
    Cancer Sci; 2015 Aug; 106(8):1041-9. PubMed ID: 26079208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-inducible factor-1 in human breast and prostate cancer.
    Kimbro KS; Simons JW
    Endocr Relat Cancer; 2006 Sep; 13(3):739-49. PubMed ID: 16954428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
    De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
    Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-glucan from Lentinus edodes inhibits breast cancer progression via the Nur77/HIF-1α axis.
    Zhang X; Li T; Liu S; Xu Y; Meng M; Li X; Lin Z; Wu Q; Xue Y; Pan Y; Alitongbieke G
    Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33245358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia inducible factor-1α/vascular endothelial growth factor signaling activation correlates with response to radiotherapy and its inhibition reduces hypoxia-induced angiogenesis in lung cancer.
    Zhu H; Zhang S
    J Cell Biochem; 2018 Sep; 119(9):7707-7718. PubMed ID: 29904944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the targeting of HIF-1α and future therapeutic strategies for glioblastoma multiforme (Review).
    Wang G; Wang JJ; Fu XL; Guang R; To ST
    Oncol Rep; 2017 Feb; 37(2):657-670. PubMed ID: 27959421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of HIF-1α-mediated metabolic adaption by NRF2-silencing in breast cancer cells.
    Lee S; Hallis SP; Jung KA; Ryu D; Kwak MK
    Redox Biol; 2019 Jun; 24():101210. PubMed ID: 31078780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer.
    Jia X; Hong Q; Lei L; Li D; Li J; Mo M; Wang Y; Shao Z; Shen Z; Cheng J; Liu G
    Oncotarget; 2015 Apr; 6(11):8648-62. PubMed ID: 25929338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.